WhiteLab Genomics
Ori Cohen is a Managing Partner at V6 Ventures, where expertise lies in fintech, health tech, Gen AI, blockchain, and IoT within a startup incubator and accelerator environment. With a rich background in various leadership roles, Ori serves as a board member and interim Chief Innovation and Product Officer for several fast-growing companies, focusing on enhancing innovative value propositions and management strategies. Previous positions include Global Head of Tech Innovation and CTO at AXA, Managing Partner at CIIF Capital LLP, and CEO roles at Kentaura Pte Ltd and Fotegrafik. Ori holds an MBA from The University of Chicago Booth School of Business and has extensive experience in M&A, venture capital, and business development across multiple tech sectors.
This person is not in any offices
WhiteLab Genomics
WhiteLab Genomics develops a proprietary platform that leverages graph knowledge technology and machine learning to help companies discover and design new genomic therapies. WhiteLab Genomics enables genomic medicine scientists to obtain precise and comprehensive answers to key scientific and technological questions such as optimizing payload andvector design, assessing genotoxicity, and identifying optimal experimental protocols for in vivo and in vitro strategies. Whitelab Genomics guides its clients through the in-silico development phases, allowing them to quickly develop target vectors and payloads while saving valuable time needed to provide patients with access to new genomic therapies.